Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Just nine months after emerging from stealth with a $ ... In a phase 1/2 trial reported last week, MET-097i achieved up to 11.3% mean placebo-adjusted weight loss at 12 weeks and exhibited a ...